![]() |
Mass Spec Protein Assays in FFPE TissueWe are advancing personalized medicine with assays that measure actual proteins in cancer signaling networks in FFPE tissue. ![]() ![]() ![]() ![]() Pharma Collaborations![]() Multiplexed Liquid Tissue®-SRM assays for major cancer signaling networks can advance development of targeted therapies and improve patient stratification. (More...) Clinical Applications![]() Our Liquid Tissue®-SRM molecular pathology tests may improve evaluation of tumors and patient selection for targeted drugs, with EGFR and IGF-1R as the initial focus. (More...) Technology![]() Our patented Liquid Tissue®-SRM technology platform measures proteins in FFPE tissue. (More...) |